Clinical research sites in Venezuela: top cities, hospitals, and investigator networks

· bioaccess® Editorial Team

Venezuela's clinical research runs through four hubs — Caracas, Valencia, Maracaibo, and Barquisimeto — with physician capacity confirmed per protocol and a fully operational private hospital sector.

Clinical research sites in Venezuela: Caracas, Valencia, Maracaibo, and Barquisimeto — infrastructure, physician capacity confirmed per protocol, and site selection criteria.

A detailed guide to clinical research sites across Venezuela — from Caracas to Maracaibo — covering hospital infrastructure, investigator qualifications, and site selection criteria for international sponsors.

July 3, 2026

13

min read

By

bioaccess® Editorial Team

clinical research sites Venezuela

Venezuela hospitals clinical trials

Caracas clinical research

Venezuela investigators

GCP-trained investigators Venezuela

**Key Takeaways**

  • • 4 major cities: Caracas, Valencia, Maracaibo, and Barquisimeto offer clinical research infrastructure
  • • physician capacity confirmed per protocol with many GCP-trained and internationally experienced
  • • Private hospital sector remains fully operational with modern equipment
  • • bioaccess® has investigators confirmed for the proposed protocol across all major cities
  • • Multi-site and multi-country trials supported through bioaccess® network

**The short answer**

Venezuela’s clinical research infrastructure concentrates in four cities — Caracas, Valencia, Maracaibo, and Barquisimeto — anchored by a fully operational private hospital sector with modern equipment. The country has physician capacity confirmed per protocol, many GCP-trained and internationally experienced, and bioaccess® maintains investigators confirmed for the proposed protocol across all four hubs. Site selection typically runs in phase 2 of the study-specific startup timeline, in parallel with regulatory strategy.

Where is Venezuela's clinical research infrastructure located?

Venezuela's clinical research landscape is anchored by a robust private hospital sector that has maintained high-quality infrastructure despite economic challenges. For sponsors evaluating first-in-human clinical trials in Venezuela, the country offers well-equipped facilities with experienced investigators across multiple therapeutic areas.

bioaccess®, as the a first-in-human CRO founded in 2010, has mapped the country's clinical research capabilities and identified top-tier sites across four major cities.

Caracas: the capital hub

Caracas, Venezuela's capital and largest city, is the primary center for clinical research in the country. The city offers:

  • Largest concentration of private hospitals and specialty clinics
  • Teaching hospitals with active research programs
  • Access to specialists across all therapeutic areas
  • International airport (Simón Bolívar) for sponsor and monitor travel
  • Concentration of pharmaceutical companies and regulatory agency offices

Valencia: industrial and medical center

Valencia, Venezuela's third-largest city and a major industrial center, offers a growing clinical research infrastructure:

  • Strong private hospital network with modern diagnostic capabilities
  • Large patient population with diverse disease profiles
  • Well-connected by highway to Caracas (2 hours) for monitoring visits
  • University medical centers with research-oriented faculty
  • Lower operational costs than Caracas while maintaining quality

Maracaibo: western Venezuela

Maracaibo, the capital of Zulia state and Venezuela's second-largest city, serves as the western hub for clinical research:

  • Major university hospital (Hospital Universitario de Maracaibo) with research tradition
  • Large patient catchment area covering western Venezuela
  • Specialty expertise in cardiovascular, metabolic, and tropical diseases
  • International airport for direct travel access
  • Diverse patient demographics for enrollment diversity

Barquisimeto: central-western hub

Barquisimeto, Venezuela's fourth-largest city, offers additional site options:

  • Strong medical infrastructure for a mid-sized city
  • University-affiliated hospitals with research capacity
  • Strategic geographic location in central-western Venezuela
  • Treatment-naïve patient populations in surrounding areas
  • Cost-effective site option for multi-center studies

What qualifications and capabilities do Venezuelan investigators have?

Venezuelan investigators bring strong qualifications to clinical research:

QualificationAvailabilityNotes
MD with specialty trainingHighStrong medical education system
ICH-GCP certificationModerate-Highbioaccess® provides training as needed
Prior clinical trial experienceModerateGrowing with bioaccess® operations
International training/fellowshipModerateMany trained in the US
Bilingual (Spanish-English)Moderate-HighFacilitates sponsor communication
Sub-specialty expertiseHighAvailable across therapeutic areas

How should sponsors select sites in Venezuela?

bioaccess® evaluates potential clinical trial sites in Venezuela using a comprehensive set of criteria:

  • Investigator expertise: therapeutic area experience and GCP training
  • Patient access: enrollment potential based on disease prevalence and catchment area
  • Facility capabilities: laboratory, pharmacy, imaging, and specialty equipment
  • Regulatory compliance: clean inspection history and proper documentation systems
  • Staff availability: dedicated study coordinators and sub-investigators
  • Geographic accessibility: monitoring visit logistics and travel feasibility
  • IRB/ethics committee: established, responsive institutional ethics committee

A city list is not a feasibility result. A protocol-specific country assessment has to confirm sites, investigators and recruitment for the proposed study.

Is GCP-trained staff available in Venezuela?

bioaccess® ensures all investigators and study staff in its Venezuelan network meet international GCP standards. Our training program includes:

  • ICH-GCP E6(R2) certification for all PIs and sub-investigators
  • Protocol-specific training sessions for each new study
  • eCRF/EDC system training for data entry staff
  • Safety reporting and pharmacovigilance training
  • Ongoing GCP refresher courses and updates

How does bioaccess®'s investigator network help sponsors?

bioaccess® has built a investigators confirmed for the proposed protocol across Venezuela's major cities, enabling rapid site identification and activation for sponsors. Our network includes specialists in cardiology, oncology, neurology, dermatology, ophthalmology, orthopedics, and rare diseases.

**Need sites in Venezuela?**

bioaccess® can identify and activate clinical trial sites in Venezuela within weeks. Contact us for a site feasibility assessment, or explore our site search and selection services.

Frequently asked questions

Planning your next step in Venezuela?

Explore clinical-trial planning for protocol-specific research questions, or medical-device registration and market access for SACS documentation and local registration arrangements. These are separate regulatory workstreams.

Get your FIH roadmap for Venezuela

bioaccess® has the sites, investigators, and infrastructure to support your clinical trial in Venezuela.

Get your FIH roadmap

View case studies

Frequently asked questions

What are the best cities for clinical trials in Venezuela?

The top cities for clinical research in Venezuela are Caracas (capital, largest hospital network), Valencia (strong medical infrastructure), Maracaibo (western hub, large patient population), and Barquisimeto (central-western medical center). bioaccess® has sites confirmed for the proposed protocol in all four cities.

Are Venezuelan investigators GCP-trained?

Yes. Many Venezuelan investigators hold current ICH-GCP certifications and have participated in international clinical trials. bioaccess® verifies GCP training for all investigators in its network and provides additional training where needed.

What hospital infrastructure is available for clinical trials in Venezuela?

Venezuela's private hospital sector maintains well-equipped facilities with modern laboratories, imaging capabilities (MRI, CT, PET), catheterization labs, surgical suites, and dedicated research units. The private hospital infrastructure remains fully operational and suitable for complex clinical research.

How does bioaccess® select clinical trial sites in Venezuela?

bioaccess® evaluates sites based on: investigator expertise and GCP training, patient access and enrollment potential, facility capabilities (lab, pharmacy, imaging), regulatory compliance history, staff availability and experience, and geographic accessibility for monitoring.

Can multi-site trials be conducted in Venezuela?

Yes. bioaccess® supports multi-site clinical trials across multiple Venezuelan cities, as well as multi-country trials spanning Venezuela, Colombia, Mexico, Brazil, and other LATAM markets. Multi-site studies in Venezuela benefit from diverse patient populations and faster aggregate enrollment.

Topics

← Back to Blog · Contact bioaccess®